ClinicalTrials.gg
Enrolling by invitationNCT05955950GReATCAREUpdated Jul 21, 2023

Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction

An interventional study of Gratitude list and List of any event in Myocardial Infarction, Acute, sponsored by Instituto de Cardiologia do Rio Grande do Sul. Enrolling by invitation at 1 site in Brazil. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-07-21.

Sponsored by Instituto de Cardiologia do Rio Grande do Sul · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as enrolling by invitation.
  • Registered 7 months after the study started (first participant enrolled Nov 2022, registered Jun 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Myocardial Infarction with a site in Brazil — 7 open to participants now, 12 under way, 7 of them phase 3. Myocardial Infarction · Brazil.

Planned enrollment
36th of 49
132 · median 2,118
Started
2022
with 1 other
No phase
9 of 64
3 open now
Primary completion
2023-11
later than 0 of 11 live
Registered
59th of 64
by date
Lead sponsor
2 of 64
Instituto de Cardiologia do Rio Grande do Sul

Among the 64 studies in Myocardial Infarction with a site in Brazil, this one is the 36th largest by planned enrollment of the 49 interventional ones that give a count, is one of 2 that started in 2022, is one of 9 with no phase, reaches primary completion later than 0 of the 11 other live ones, and was the 59th registered.

Myocardial Infarction

2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.

Browse Myocardial Infarction studies →

Open to participants now

7 of the 64 studies in Myocardial Infarction with a site in Brazil are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Myocardial Infarction with a site in Brazil, or all of them as a file.
02

Study summary

Introduction: Positive psychological's constructs have shown a direct effect on adherence to pharmacological treatment, diet, physical activity and general commitment to health, in the same way that negative ones, such as depression, anxiety and stress, are associated with worse cardiovascular outcomes and are prevalent in patients with infarction. Objective: To verify whether a gratitude intervention can improve self-care and improve negative psychological states in patients with recent myocardial infarction. Methods: Randomized, parallel clinical trial. The inclusion criteria will be patients with ST-segment elevation myocardial infarction (STEMI) with less than 12 hours of evolution and undergoing primary percutaneous coronary intervention (pPCI). Participants will respond to the socio-demographic and risk factors questionnaire and self-care (ASA-A), anxiety, depression and stress (DASS-21) and gratitude (QG-6) scales. They will be drawn into the gratitude intervention group or neutral events group according to the randomization list. Patients in the intervention group will be tasked with writing down 3 to 5 situations a day for which they are grateful, for 14 days. Patients in the control group will be asked to write down 3 to 5 situations a day that have impacted them, whether good or bad. Both groups will be reassessed after the intervention and after 6 months. Expected results: It is expected that the intervention group will improve self-care and the feeling of gratitude, modify behaviors and decrease negative affects, while the group without intervention will remain unchanged from the beginning of the study to 6 months.

Read the detailed description

Study design: Randomized, parallel clinical trial. The study will use a prospective experimental design with Condition and Time as independent variables. The condition has two levels that correspond to the experimental conditions: (a) Gratitude List (aspects of daily experience that one feels grateful for), (b) Any Event List (events of one's own choosing that impressed the participant during the day, whether positive or negative). Time is a repeated measures variable with three levels corresponding to the measurement times: (a) Pre-test (before the intervention), (b) Post-test (at 2 weeks after of the intervention - visit 1) and (c) ) Follow-up (from baseline to 6 months - visit 2).

This follow-up period is based on the previous studies. Patients will be invited to participate in the study during hospitalization for AMI. If they agree to participate, they must sign the Free and Informed Consent Form. They will answer the socio-demographic questionnaire and risk factors and self-care scales (ASA-A), anxiety, depression and stress (DASS-21) and gratitude (QG-6).

Envelopes will be opened after the initial interview. Participants will receive instructions for the intervention. Participants will be asked to allocate 10-20 minutes at the end of the day, before bed, for 14 days, to write the lists, according to their allocation group. Studies involving gratitude interventions generally last for two weeks as already explained.

In each group, participants will make a list of up to five items, evaluating the activities of that day. The instructions for the groups were adapted and translated.

For the intervention group (Gratitude List), the instructions will be:

"During the day, many things happen in our lives, big and small, for which we can be grateful. Think about your day and write down up to five things in your life that you are grateful for."

For the control group (List of any event), the instructions were:

"During the day, there are many events in our lives, big and small, that end up affecting us. Think about your day and write down up to five things in your life that affected you." Patients will receive a small notebook for daily notes, starting on the day of discharge. Upon discharge, text messages will be sent to their cell phones with reminders not to forget to start and continue making lists. At the end of 2 weeks of the intervention, patients will be invited to return for a reassessment interview (visit 1), and again at the end of 6 months (visit 2). A 6-month follow-up will be necessary so that we can assess changes in behavior.

To assess the improvement in self-care, the ASA-A scale will be used. To assess emotional factors, the DASS scale (which assesses anxiety, depression and stress) will be used. To assess gratitude in the face of life events, the QG-6 scale and for physical health, a dedicated questionnaire will be used. All scales will be used before and after.

03

Conditions studied

  • Myocardial Infarction, Acute

Keywords

  • Psychosocial intervention
  • positive psychology
  • mental health
  • self-care,
  • Myocardial infarction
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ST-segment elevation myocardial infarction (STEMI) patients
  • Undergoing primary percutaneous coronary intervention (pPCI).

Exclusion criteria

Exclusion Criteria:

  • Patients in need of ventilatory support;
  • Over 75 years of age;
  • Delirium or dementia reported by the attending physician.
  • Not able to answer the questionnaires.
  • Very high depression scores requiring referral to psychological care services
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Gratitude List

    Participants must to write 3-5 words a day for 14 days about aspects of their daily experience that they are grateful for.

    Behavioral: Gratitude list

  • Active comparator
    List of any event

    Participants must to write 3-5 words a day for 14 days about events of your own choosing that impressed the participant during the day, whether positive or negative.

    Behavioral: List of any event

Interventions

  • BehavioralGratitude list

    Participants must to write 3-5 words a day for 14 days about aspects of their daily experience that they are grateful for.

  • BehavioralList of any event

    Participants must to write 3-5 words a day for 14 days about events of your own choosing that impressed the participant during the day, whether positive or negative.

06

What researchers measure

Primary outcomes

  1. Changes in self-care scores

    Changes in self-care scores assessed from Appraisal of Self-care Agency (ASA)

    Time frame: From baseline to 15 days and from baseline to 6 months

  2. Changes in negative psychological states

    Changes in DASS-21 scores

    Time frame: From baseline to 15 days and from baseline to 6 months

Secondary outcomes

  1. Changes in gratitude scores

    Changes in Gratitude Questionnaire - GQ-6 scores

    Time frame: From baseline to 15 days and from baseline to 6 months

  2. Behavioral changes (physical activity, diet...)

    Changes in modifiable cardiovascular risk factors: cholesterol, triglycerides, smoking cessation, etc.

    Time frame: From baseline to 15 days and from baseline to 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Nov 2023, 12 months after the start.

Of 322 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's planned 12 months is below that.

Counting every sponsor, half of 355 studies reached it within 34 months; a quarter within 15 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2023
First posted
Jul 21, 2023
StartActual
Nov 5, 2022
Primary completionEst.
Nov 5, 2023
CompletionEst.
Jul 5, 2024
Last update
Jul 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05955950
Lead sponsor
Instituto de Cardiologia do Rio Grande do Sul
Responsible party
Sponsor
First posted
Jul 21, 2023
Start date
Nov 5, 2022
Primary completion
Nov 5, 2023 (estimated)
Completion
Jul 5, 2024 (estimated)
Last update
Jul 21, 2023

Study contacts

MARCIA M SCHMIDT
principal investigator · Institute of Cardiology of Rio Grande do Sul

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion